Medicine
Mycophenolate 250 mg capsule
Mycophenolate 250 mg capsule is a generic prescription medicine for oral use, made by 17 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F)…
Key facts
- Active ingredient (INN)
- Mycophenolate
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 500 capsules, 100 capsules, 10 blister pack and 31 more
- Manufacturers
- Ascend LaboratoriesIndiaStrides PharmaIndiaAccord HealthcareIndiaAurobindo PharmaIndiaAvet PharmaceuticalsIndiaCamber PharmaceuticalsIndiaConcord BiotechIndiaSandozAdvagen PharmaAvKARE
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F) Mycophenolate mofetil tablets USP 500 mg Tablets: Lavender-colored, caplet-shaped, film coated tablets, debossed with "C4" on one side and plain on the other side Sizes Bottle of 100 NDC 72888-185-01 Bottle of 500 NDC 72888-185-05 Storage and Dispensing Information: Store at 25°C (77°F), excursions permitted to 15°C to 30°C…
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AA06 Mycophenolate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 October 2008
- Identifiers
- RxCUI 199058, 200060DailyMed set ID a15c26d8-5a27-48ba-a669-8546803d901f, 99b2eb58-8d14-48fc-bbe1-aacb711a783e, 32dd890a-cfe3-4129-bce6-1d3dbe38e4f3 +16NDC 72888-192, 0781-2067, 64380-726 +16Application ANDA210181, ANDA065379, ANDA090055 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 500 capsule in 1 bottle, plastic | 42543-988-07 | Strides PharmaIndia | 28 February 2025 |
| 100 capsule in 1 bottle, plastic | 64380-726-06 | Strides PharmaIndia | 6 November 2010 |
| 500 capsule in 1 bottle, plastic | 64380-726-07 | Strides PharmaIndia | 6 November 2010 |
| 100 capsule in 1 bottle | 16729-094-01 | Accord HealthcareIndia | 4 May 2009 |
| 500 capsule in 1 bottle | 16729-094-16 | Accord HealthcareIndia | 4 May 2009 |
| 100 capsule in 1 bottle | 67877-266-01 | Ascend LaboratoriesIndia | 1 January 2010 |
| 500 capsule in 1 bottle | 67877-266-05 | Ascend LaboratoriesIndia | 1 January 2010 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 67877-266-38 | Ascend LaboratoriesIndia | 1 January 2010 |
| 3 blister pack in 1 carton / 10 capsule in 1 blister pack | 67877-266-84 | Ascend LaboratoriesIndia | 1 January 2010 |
| 100 capsule in 1 bottle | 59651-624-01 | Aurobindo PharmaIndia | 5 January 2024 |
| 500 capsule in 1 bottle | 59651-624-05 | Aurobindo PharmaIndia | 5 January 2024 |
| 100 capsule in 1 bottle, plastic | 23155-830-01 | Avet PharmaceuticalsIndia | 30 June 2022 |
| 500 capsule in 1 bottle, plastic | 23155-830-05 | Avet PharmaceuticalsIndia | 30 June 2022 |
| 1 bottle in 1 carton / 100 capsule in 1 bottle | 31722-878-01 | Camber PharmaceuticalsIndia | 22 October 2024 |
| 500 capsule in 1 bottle | 31722-878-05 | Camber PharmaceuticalsIndia | 12 December 2024 |
| 100 capsule in 1 bottle | 68254-5000-1 | Concord BiotechIndia | 1 October 2019 |
| 500 capsule in 1 bottle | 68254-5000-2 | Concord BiotechIndia | 1 October 2019 |
| 100 capsule in 1 bottle | 72888-192-01 | Advagen Pharma | 1 August 2023 |
| 500 capsule in 1 bottle | 72888-192-05 | Advagen Pharma | 1 August 2023 |
| 100 capsule in 1 bottle | 0781-2067-01 | Sandoz | 15 October 2008 |
| 500 capsule in 1 bottle | 0781-2067-05 | Sandoz | 15 October 2008 |
| 120 capsule in 1 bottle | 0781-2067-72 | Sandoz | 15 October 2008 |
| 12 capsule in 1 carton | 0781-2067-89 | Sandoz | 15 October 2008 |
| 100 capsule in 1 bottle | 0093-7334-01 | Teva Pharmaceuticals | 6 May 2009 |
| 500 capsule in 1 bottle | 0093-7334-05 | Teva Pharmaceuticals | 6 May 2009 |
| 100 capsule in 1 bottle, plastic | 65050-2073-0 | Wuxi Fortune Pharmaceutical Co.,Ltd | 10 November 2025 |
| 100 pouch in 1 box / 1 capsule in 1 pouch | 70518-3799-0 | Remedyrepack | 18 July 2023 |
| 100 pouch in 1 box / 1 capsule in 1 pouch | 70518-4036-0 | Remedyrepack | 11 March 2024 |
| 100 blister pack in 1 carton / 1 capsule in 1 blister pack | 60687-885-01 | American Health Packaging | 2 April 2025 |
| 100 capsule in 1 bottle | 73190-009-01 | AvKARE | 25 April 2025 |
| 500 capsule in 1 bottle | 73190-009-50 | AvKARE | 25 April 2025 |
| 50 blister pack in 1 box / 1 capsule in 1 blister pack | 50268-557-15 | AvPAK | 15 May 2023 |
| 10 blister pack in 1 bag / 1 capsule in 1 blister pack | 55154-0161-0 | Cardinal Health | 14 September 2026 |
| 100 blister pack in 1 carton / 1 capsule in 1 blister pack | 0904-7466-61 | Major Pharmaceuticals | 11 December 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Mycophenolate 250 mg capsule.
Other strengths and forms of Mycophenolate
Clinical summary
Mycophenolate is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. MedsAcross supplies Mycophenolate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MycophenolateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CellCept prescribing information (Genentech) · U.S. National Library of Medicine, DailyMed
- CellCept: European public assessment report (EPAR) · European Medicines Agency
- Myclausen: European public assessment report (EPAR) · European Medicines Agency
Need Mycophenolate 250 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.